Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...

For millions of asthma sufferers worldwide, the distinctive puff of an inhaler represents a lifeline, providing instant relief from constricted airways. Dr Juma Bwika, a pulmonologist at Aga Khan ...

The family of a man who had an asthma attack and died last year on a British Airways flight from London to New York is now ...

Take the market for albuterol inhalers, filled with fast-acting drugs meant to stop an asthma attack in its tracks. Before the propellant switch, annual sales for the three brand-name inhalers had ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...

Doctors could be taught to limit the use of traditional asthma inhalers due to their environmental impact. This initiative, led by the University of Glasgow and coordinated by the European ...

Details of the study were presented in a session at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting (ACAAI 2024) in Boston. Reliever inhalers, including ...

Those using a rescue inhaler during an asthma attack, especially, may want a propellant to help push the medicine into their airways. This is why GSK Plc is focusing on lowering the emissions of ...

Early fall is when asthma flare-ups peak in the US ... Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade.